Inhibition of p300 and nuclear factor-kappaB by curcumin and its role in diabetic nephropathy.
Kurien
Biji T
BT
D000818:Animals; D003474:Curcumin / Q000008:administration & dosage* / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D004121:Dimethyl Sulfoxide / Q000009:adverse effects*; D050881:E1A-Associated p300 Protein / Q000037:antagonists & inhibitors; D000431:Ethanol / Q000009:adverse effects; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D014677:Pharmaceutical Vehicles; D008517:Phytotherapy; D051381:Rats
D016328:NF-kappa B; D014677:Pharmaceutical Vehicles; D000431:Ethanol; D050881:E1A-Associated p300 Protein; C494360:EP300 protein, human; D003474:Curcumin; D004121:Dimethyl Sulfoxide